Obesity induces lipotoxic cardiomyopathy, a condition in which lipid accumulation in cardiomyocytes causes cardiac dysfunction. Here, we show that glycogen synthase kinase-3a (GSK-3a) mediates lipid accumulation in the heart. Fatty acids (FAs) upregulate GSK-3a, which phosphorylates PPARa at Ser280 in the ligand-binding domain (LBD). This modification ligand independently enhances transcription of a subset of PPARa targets, selectively stimulating FA uptake and storage, but not oxidation, thereby promoting lipid accumulation. Constitutively active GSK-3a, but not GSK-3b, was sufficient to drive PPARa signaling, while cardiac-specific knockdown of GSK-3a, but not GSK-3b, or replacement of PPARa Ser280 with Ala conferred resistance to lipotoxicity in the heart. Fibrates, PPARa ligands, inhibited phosphorylation of PPARa at Ser280 by inhibiting the interaction of GSK-3a with the LBD of PPARa, thereby reversing lipotoxic cardiomyopathy. These results suggest that GSK-3a promotes lipid anabolism through PPARa-Ser280 phosphorylation, which underlies the development of lipotoxic cardiomyopathy in the context of obesity.